ATTENTION: HOURS OF OPERATION  MAY 23 – MAY 27, 2019

Due to team in-service activities, HealthWell Foundation’s hotline will open at 10:30 a.m. on Thursday, May 23, 2019.

In addition, HealthWell Foundation headquarters and hotline will be closing at 3:00 p.m. on Friday, May 24th and will be closed on Monday,  May 27th in observance of the Memorial Day holiday. Our office and hotline will re-open on Tuesday, May 28th at 9:00 a.m.

We encourage you to continue to use our Patient, Pharmacy and Provider Portals during these times.  Please note: if you are contacting us about a payment or grant, it is faster to email us at grants@healthwellfoundation.org.  Thank you for your patience during these adjusted hours. The HealthWell Team wishes you and yours a happy, safe and healthy holiday.

Dismiss alert

Chronic Lymphocytic Leukemia - Medicare Access (Medicare patients only)

Treatments Covered

  • Adriamycin
  • Arranon
  • Arzerra
  • Bendeka
  • Betamethasone
  • Calquence
  • Cladribine
  • Copiktra
  • Cyclophosphamide
  • Cytarabine
  • Decadron
  • Etoposide Novaplus
  • Fludarabine
  • Gazyva
  • Hydrocortisone
  • Imbruvica
  • Imbruvica/gazyva Combo
  • Immune Globulin
  • Keytruda
  • Lemtrada
  • Leukeran
  • Medrol
  • Millipred
  • Millipred Dp
  • Mitoxantrone
  • Nipent
  • Opdivo
  • Otrexup
  • Prednisone
  • Rasuvo
  • Revlimid
  • Rituxan
  • Rituxan Hycela
  • Toposar
  • Toposar Novaplus
  • Treanda
  • Valchlor
  • Venclexta
  • Vincasar
  • Xatmep
  • Zydelig

Fund Definition

Assistance with the prescription drugs and biologics used in the treatment of chronic lymphocytic leukemia.

Consider Premium Assistance

Under this fund, HealthWell can assist with premium costs. Medicare supplemental policies can help with cost shares related to many aspects of your health care. Using a HealthWell grant to cover premiums may be a better option than treatment-specific cost shares.

Do I Qualify?

HealthWell bases eligibility on an individual’s medical, financial and insurance situation. To qualify for HealthWell’s assistance, applicants must meet the following eligibility requirements:

  • 1.You are being treated for Chronic Lymphocytic Leukemia.

    Please make sure that HealthWell currently has a fund for your diagnosis/indication and that your medication is covered under that fund by visiting our Disease Funds listing. If we do not have a fund that currently covers your diagnosis, please check back as we frequently open and reopen programs as funding becomes available. The Foundation is able to help patients receiving treatment for indications for which we currently have an open fund. We can only assist with medications that have been prescribed to treat the disease/covered diagnosis. You will be asked to provide the Foundation with the patient’s diagnosis, which must be verified by a physician, nurse practitioner, or physician assistant’s signature. The patient must receive treatment in the United States.

  • 2.You have Medicare.

    This is a Medicare Access Fund. In order to qualify for assistance through this fund, you must have Medicare. The Foundation will refer patients without Medicare to other programs, such as manufacturer patient assistance programs.

  • 3.Your income falls within our guidelines.
    HealthWell assists individuals with incomes up to 400-500% of the Federal Poverty Level. The Foundation also considers the number in a household and cost of living in a particular city or state. If you believe you qualify for assistance, you may begin the application process here.
  • 4.You are receiving treatment in the United States.

    If you are receiving treatment in the U.S. and have met the eligibility criteria as listed, you are ready to apply! Please note that you will be asked to provide a Social Security Number in order to create a grant. This information is gathered to eliminate duplicate applications and is kept secure and confidential.

About Chronic Lymphocytic Leukemia

Leukemia is cancer that starts in the blood-forming cells of the bone marrow. When one of these cells changes and becomes a leukemia cell, it no longer matures the way it should and grows out of control. Often, it divides to make new cells faster than normal. According to the American Cancer Society, chronic lymphocytic leukemia (CLL) is the most common leukemia in adults. CLL starts in cells that become certain white blood cells (called lymphocytes) in the bone marrow. The cancer (leukemia) cells start in the bone marrow but then go into the blood.

In CLL, the leukemia cells often build up slowly. Over time, the cells grow and spread to other parts of the body, including the lymph nodes, liver, and spleen. Source: American Cancer Society